Debra Odink

2010

In 2010, Debra Odink earned a total compensation of $446.2K as Chief Technology Officer, Pharmaceutical Research and Development at Anthera Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$80,000
Salary$232,179
Stock Awards$134,000
Total$446,179

Odink received $232.2K in salary, accounting for 52% of the total pay in 2010.

Odink also received $80K in non-equity incentive plan and $134K in stock awards.

Rankings

In 2010, Debra Odink's compensation ranked 8,100th out of 10,439 executives tracked by ExecPay. In other words, Odink earned more than 22.4% of executives.

ClassificationRankingPercentile
All
8,100
out of 10,439
22nd
Division
Manufacturing
3,009
out of 3,838
22nd
Major group
Chemicals And Allied Products
718
out of 921
22nd
Industry group
Drugs
503
out of 680
26th
Industry
Pharmaceutical Preparations
376
out of 481
22nd
Source: SEC filing on April 5, 2013.

Odink's colleagues

We found four more compensation records of executives who worked with Debra Odink at Anthera Pharmaceuticals in 2010.

2010

Paul Truex

Anthera Pharmaceuticals

Chief Executive Officer

2010

Christopher Lowe

Anthera Pharmaceuticals

Chief Financial Officer

2010

Colin Hislop

Anthera Pharmaceuticals

Chief Medical Officer

2010

Georgina Kilfoil

Anthera Pharmaceuticals

Senior Vice President, Product Development

You may also like